1-5 of 5
Heather J. Landau
Close
Sort by
Journal Articles

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Anna J. Howard, Isabel Concepcion, Alice X. Wang, Issam S. Hamadeh, Malin Hultcrantz, Sham Mailankody, Carlyn Tan, Neha Korde, Alexander M. Lesokhin, Hani Hassoun, Urvi A. Shah, Kylee H. Maclachlan, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Oscar B. Lahoud, David J. Chung, Sergio Giralt, Saad Z. Usmani, Ross S. Firestone
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3246–3253.
https://doi.org/10.1182/bloodadvances.2024012871
Published: 2024
Includes: Supplemental data
Journal Articles

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Clinical Trials & Observations
Issam S. Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S. Firestone, Alice X. Wang, Neha Korde, Malin L. Hultcrantz, Alexander M. Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A. Shah, Kylee Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L. Shah, Michael Scordo, Oscar B. Lahoud, David J. Chung, Heather J. Landau, Sergio Giralt, Saad Z. Usmani, Carlyn R. Tan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3038–3044.
https://doi.org/10.1182/bloodadvances.2024012724
Published: 2024
Journal Articles

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Ross S. Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R. Tan, Malin Hultcrantz, Sham Mailankody, Hani Hassoun, Urvi S. Shah, Neha Korde, Kylee H. Maclachlan, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Oscar B. Lahoud, Sergio Giralt, Kazunori Murata, Kinga K. Hosszu, David J. Chung, Alexander M. Lesokhin, Saad Z. Usmani
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1600–1611.
https://doi.org/10.1182/bloodadvances.2023011225
Published: 2024
Includes: Supplemental data
Journal Articles

Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation

Clinical Trials & Observations
Michael Scordo, Leah J. Gilbert, Danielle M. Hanley, Jessica R. Flynn, Sean M. Devlin, Linh K. Nguyen, Josel D. Ruiz, Gunjan L. Shah, Craig S. Sauter, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Richard J. Lin, Parastoo B. Dahi, Miguel-Angel Perales, Sergio A. Giralt, Gerald A. Soff
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1536–1544.
https://doi.org/10.1182/bloodadvances.2022007838
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis

Clinical Trials & Observations
Cara A. Rosenbaum, Umut Özbek, Larysa Sanchez, Jonathan Lagdameo, Alex Abrahams, Hani Hassoun, Oscar Lahoud, Ruben Niesvizky, Heather J. Landau, Keren Osman
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5436–5439.
https://doi.org/10.1182/bloodadvances.2022007826
Published: 2022